Primo Nutraceuticals (BUGVF)
OTHER OTC:BUGVF
US Market
Holding BUGVF?
Track your performance easily

Primo Nutraceuticals (BUGVF) Income Statement

8 Followers

Primo Nutraceuticals Income Statement

Last quarter (Q3 2020), Primo Nutraceuticals's total revenue was C$―, a decrease of ― from the same quarter last year. In Q3, Primo Nutraceuticals's net income was C$-390.38K. See Primo Nutraceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jul 19Jul 18Jul 17Jul 16
Total Revenue
-----
Cost of Revenue
-----
Gross Profit
-----
Operating Expense
C$ 1.50MC$ 1.40MC$ 748.56KC$ 51.18KC$ 47.24K
Operating Income
C$ -1.50MC$ -1.40MC$ -748.56KC$ -51.18KC$ -47.24K
Net Non Operating Interest Income Expense
C$ 1.97KC$ 2.50KC$ 1.74K--
Other Income Expense
C$ -2.34MC$ -3.72MC$ -33.31KC$ -3.65K-
Pretax Income
C$ -3.84MC$ -5.13MC$ -783.61KC$ -54.82KC$ -47.24K
Tax Provision
-----
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
C$ -3.84MC$ -5.13MC$ -783.61KC$ -54.82KC$ -47.24K
Basic EPS
C$ -12.00C$ -18.00C$ -3.45C$ -0.30C$ -0.15
Diluted EPS
C$ -12.00C$ -18.00C$ -3.45C$ -0.30C$ -0.15
Basic Average Shares
C$ 2.02MC$ 291.95KC$ 227.43KC$ 227.43KC$ 227.43K
Diluted Average Shares
C$ 2.02MC$ 291.95KC$ 227.43KC$ 227.43KC$ 227.43K
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
C$ -1.50MC$ -1.40MC$ -748.56KC$ -51.18KC$ -47.24K
Net Income From Continuing And Discontinued Operation
C$ -3.84MC$ -5.13MC$ -783.61KC$ -54.82KC$ -47.24K
Normalized Income
C$ -2.69MC$ -211.84KC$ -575.95KC$ -40.29KC$ -34.72K
Interest Expense
-----
EBIT
C$ -3.84MC$ -5.13MC$ -783.61KC$ -54.82KC$ -47.24K
EBITDA
C$ -3.84MC$ -5.13MC$ -783.61KC$ -54.82KC$ -47.24K
Currency in CAD

Primo Nutraceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis